Meet Our Experts
At NanoMedX, our scientists and leaders are united by a single goal — delivering non-invasive gene therapies that transform lives.
With decades of expertise in biotech, research, and commercialization, we’re building tomorrow’s healthcare today.
Leadership & Scientific Advisory
Our Team
Meet the leadership and advisors pioneering our next-generation gene therapy platform.
Leadership
Dr. Richard Boudreault
CEO
Leading our corporate strategy and growth with extensive biotech experience.
Affiliation: École Polytechnique de Montréal.
Affiliation: École Polytechnique de Montréal.
Gilbert Tordjman
COO
Leading operations that power innovation.
Affiliation: Montreal Clinical Research Institute (IRCM), Montreal Children's Hospital Foundation, Lady Davis Institute for Medical Research at the Jewish General Hospital, Federation CJA, RI-MUHC.
Affiliation: Montreal Clinical Research Institute (IRCM), Montreal Children's Hospital Foundation, Lady Davis Institute for Medical Research at the Jewish General Hospital, Federation CJA, RI-MUHC.
Dr. Eli BenDavid
Founder, CTO, CMO
Leading our product engineering design & development, as well as clinical translation/applications.
Ariel Cozocaru
Executive VP
Leading our partnerships and investor relations.
Joel Rousseau
Director of Genetic Engineering
Leading our prime editors design and development.
Board of Advisors
Dr. Jacques P. Tremblay
Gene Therapy Advisor
Expert researcher in neurodegenerative diseases, gene therapy, and RNA-based therapeutics.
Affiliation: Université Laval; Director of Molecular Medicine and Gene Therapy Laboratory, CHU de Québec.
Affiliation: Université Laval; Director of Molecular Medicine and Gene Therapy Laboratory, CHU de Québec.
Dr. Avi Schroeder
Chemical Engineering Advisor
Expert in nanomedicine, targeted drug delivery, and personalized medicine.
Affiliation: Technion – Israel Institute of Technology; Director of Laboratory for Targeted Drug Delivery & Personalized Medicine Technologies.
Affiliation: Technion – Israel Institute of Technology; Director of Laboratory for Targeted Drug Delivery & Personalized Medicine Technologies.
Dr. Nicolas Bertrand
Pharmacology Advisor
Expert in advancements in nanomedicine, pharmacology, and pharmaceutical nanoscience.
Affiliation: Université Laval; Director of NanoPharmacology and Pharmaceutical NanoScience Laboratory, CHU de Québec.
Affiliation: Université Laval; Director of NanoPharmacology and Pharmaceutical NanoScience Laboratory, CHU de Québec.
Dr. Gary Zweiger
Scientific Advisor
Expert in Genetics and Biotech Venture Capital.
Affiliation: RNA Advisors and Fluent BioSciences (an Illumina company).
Affiliation: RNA Advisors and Fluent BioSciences (an Illumina company).
Dr. Martin Ingelsson
Scientific Advisor
Expert in immunotherapy, gene therapy, and geriatrics.
Affiliation: Krembil Research Institute, clinician-scientist at the Toronto Western Hospital / University Health Network.
Affiliation: Krembil Research Institute, clinician-scientist at the Toronto Western Hospital / University Health Network.
Dr. Marc Lavertu
Biomedical Engineering Advisor
Expert in biomedical engineering, biomaterials, drug delivery system, and gene therapy.
Affiliation: École Polytechnique de Montréal, Institute of Biomedical Engineering, Department of Chemical Engineering.
Affiliation: École Polytechnique de Montréal, Institute of Biomedical Engineering, Department of Chemical Engineering.
Dr. Eric Biron
Molecular Engineering & Organic Synthesis Advisor
Expert in design and synthesis of active moiety.
Affiliation: Université Laval, CHU de Quebec.
Affiliation: Université Laval, CHU de Quebec.